Modified Finnegan Neonatal Abstinence Score (NAS)

Pharmacologic treatment required if

The Modified Finnegan Neonatal Abstinence Score is a symptom‑based tool used to quantify opioid withdrawal severity in newborns to guide treatment decisions.

Cry
Normal0Excessive high-pitched cry < 5 min+2Continuous high-pitched cry > 5 min+3
Sleep
Normal0Sleeps < 3 hrs after feeding+1Sleeps < 2 hrs after feeding+2Sleeps < 1 hr after feeding+3
Moro reflex
Normal0Hyperactive+2Markedly hyperactive+3
Tremors
None0Mild tremors when disturbed+1Moderate-severe tremors when disturbed+2Mild tremors when undisturbed+3Moderate-severe tremors when undisturbed+4
Increased muscle tone
No0Yes+1
Excoriation (e.g., chin, knees, elbows, toes, nose)
No0Yes+1
Myoclonic jerks (twitching/jerking of limbs)
No0Yes+3
Generalized convulsions
No0Yes+5
Sweating
No0Yes+1
Hyperthermia
None037.2-38.3C (99.0-100.9F)+1>38.3C (>100.9F)+2
Frequent yawning (> 3-4x per scoring interval)
No0Yes+1
Nasal flaring
No0Yes+2
Respiratory rate
Normal0> 60 bpm, no retractions+1> 60 bpm w/ retractions+2
Excessive sucking
No0Yes+1
Poor feeding (infrequent/uncoordinated suck)
No0Yes+2
Regurgitation
No0≥ 2x during/post-feeding+2
Projectile vomiting
No0Yes+3
Stools
No0Loose (curds/seedy)+2Watery (water ring on diaper around stool)+3

适用指征

Used to assess opioid‑withdrawal severity in term or near‑term infants exposed to prenatal opioids and guide need for pharmacologic therapy. Helps standardize monitoring, track response to treatment, and determine timing/intensity of supportive care. Identifies infants at risk for complications and assists decisions on initiation, escalation, or weaning of therapy.

洞见与注意事项

Scores are highly sensitive for detecting infants needing treatment but remain subjective and inconsistently validated; shortened versions correlate well with treatment thresholds yet lack robust psychometrics 1 [Level III evidence]. Observational bias, poor internal consistency, and limited applicability to preterm infants are major cautions 2 [Level III evidence]. ESC‑based care reduces overtreatment and LOS, underscoring that score-driven algorithms may overestimate severity 3 [Level I evidence].